SCHEMBL7744162

SCHEMBL7744162

CCCCC(=O)Nc1oc(-c2ccc(-c3ccccc3)cc2O)nc1-c1ccccc1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 4/20 0.45
FLT1 P17948 1/20 0.45
FLT4 P35916 1/20 0.45
HPGD P15428 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
TSHR P16473 2/20 0.44
USP2 O75604 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ADORA1 P30542 2/20 0.43
ADORA3 P0DMS8 1/20 0.41
HSP90AA1 P07900 1/20 0.41
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 3/20 0.40
SOAT1 P35610 2/20 0.40
HSD17B10 Q99714 2/20 0.40
GSK3B P49841 1/20 0.39
AGPAT2 O15120 1/20 0.39
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39
NR4A2 P43354 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7744041 0.93 HPGD (0.46) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7739022 0.90 KDR (0.54) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7744659 0.90 KDR (0.50) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7744672 0.89 HPN (0.42) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7744192 0.88 KDR (0.51) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7744662 0.85 KDR (0.61) KDRFLT1FLT4NPSR1KDM4E
SCHEMBL7744165 0.85 HPGD (0.44) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7744651 0.84 HPGD (0.51) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7746627 0.84 KDR (0.48) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7746658 0.83 KDR (0.55) KDRFLT1FLT4HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed